Erythromycin sclerotherapy in the management of seroma.
Post-operative seroma can present the clinician and patient with a chronic and difficult problem. The authors present their experience of managing refractory seroma with the antibiotic erythromycin, administered for its properties as a sclerosant. The technique was found, in a series of patients, to be effective, simple and without serious complications.
Ali-Khan
A S
AS
Department of Plastic Surgery, Frenchay Hospital, Frenchay, Bristol BS16 1LE, UK. shoobs@doctors.org.uk
Orlando
A
A
Kenealy
J
J
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000601:surgery; D004322:Drainage / Q000379:methods; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008197:Lymph Node Excision / Q000009:adverse effects*; D008875:Middle Aged; D012008:Recurrence; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D015911:Sclerotherapy / Q000379:methods*; D049291:Seroma / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome; D014945:Wound Healing
D012597:Sclerosing Solutions; D004917:Erythromycin